Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$59.28
-2.32-3.77%
At close: -
$59.01
-0.27-0.46%
After Hours: 4:32 PM EDT
Comments
Loading...
Globus Medical Analyst Ratings and Price Targets | NYSE:GMED | Benzinga
Globus Medical Inc has a consensus price target of $88.6 based on the ratings of 18 analysts. The high is $115 issued by Roth MKM on December 17, 2024. The low is $68 issued by Truist Securities on May 12, 2025. The 3 most-recent analyst ratings were released by Truist Securities, Piper Sandler, and Truist Securities on May 12, 2025, May 9, 2025, and April 11, 2025, respectively. With an average price target of $76 between Truist Securities, Piper Sandler, and Truist Securities, there's an implied 28.79% upside for Globus Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Piper Sandler
Barclays
Stifel
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Globus Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/12/2025 | Buy Now | 15.23% | Truist Securities | Richard Newitter74% | $80 → $68 | Maintains | Hold | Get Alert |
| 05/09/2025 | Buy Now | 35.57% | Piper Sandler | Matt O'Brien52% | $100 → $80 | Maintains | Overweight | Get Alert |
| 04/11/2025 | Buy Now | 35.57% | Truist Securities | Richard Newitter74% | $82 → $80 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | 38.96% | Truist Securities | Richard Newitter74% | $90 → $82 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 02/24/2025 | Buy Now | — | Citizens Capital Markets | David Turkaly60% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/24/2025 | Buy Now | 74.55% | Barclays | Matt Miksic77% | $100 → $103 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 59.3% | Stifel | Mathew Blackman63% | $92 → $94 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 57.6% | Wells Fargo | Vik Chopra49% | $95 → $93 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 02/06/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 01/10/2025 | Buy Now | 71.16% | Canaccord Genuity | William Plovanic59% | $92 → $101 | Maintains | Buy | Get Alert |
| 01/09/2025 | Buy Now | 64.38% | B of A Securities | Craig Bijou79% | $80 → $97 | Upgrade | Underperform → Neutral | Get Alert |
| 01/09/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 12/18/2024 | Buy Now | 52.52% | Truist Securities | Richard Newitter74% | $85 → $90 | Maintains | Hold | Get Alert |
| 12/17/2024 | Buy Now | 94.88% | Roth MKM | Jason Wittes55% | $100 → $115 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 54.21% | BTIG | Ryan Zimmerman71% | $87 → $91 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 60.99% | Wells Fargo | Vik Chopra49% | $88 → $95 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 55.91% | Canaccord Genuity | William Plovanic59% | $85 → $92 | Maintains | Buy | Get Alert |
| 12/02/2024 | Buy Now | 69.46% | Morgan Stanley | Drew Ranieri47% | $83 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/11/2024 | Buy Now | 40.65% | Morgan Stanley | Drew Ranieri47% | $74 → $83 | Maintains | Equal-Weight | Get Alert |
| 11/07/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 11/06/2024 | Buy Now | 55.91% | Stifel | Mathew Blackman63% | $80 → $92 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 44.04% | Canaccord Genuity | William Plovanic59% | $79 → $85 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 69.46% | Roth MKM | Jason Wittes55% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | Buy Now | 55.91% | RBC Capital | Shagun Singh43% | $80 → $92 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 49.13% | Wells Fargo | Vik Chopra49% | $78 → $88 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 69.46% | Piper Sandler | Matt O'Brien52% | $80 → $100 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 35.57% | B of A Securities | Craig Bijou79% | $55 → $80 | Maintains | Underperform | Get Alert |
| 11/06/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 10/14/2024 | Buy Now | 32.18% | BTIG | Ryan Zimmerman71% | $77 → $78 | Maintains | Buy | Get Alert |
| 10/08/2024 | Buy Now | 35.57% | RBC Capital | Shagun Singh43% | $78 → $80 | Maintains | Outperform | Get Alert |
| 08/28/2024 | Buy Now | 30.49% | BTIG | Ryan Zimmerman71% | $75 → $77 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 57.6% | Barclays | Matt Miksic77% | $85 → $93 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 32.18% | RBC Capital | Shagun Singh43% | $76 → $78 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 33.88% | Truist Securities | Richard Newitter74% | $78 → $79 | Maintains | Hold | Get Alert |
| 08/07/2024 | Buy Now | 32.18% | Wells Fargo | Vik Chopra49% | $60 → $78 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/07/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 07/16/2024 | Buy Now | 32.18% | Truist Securities | Richard Newitter74% | $63 → $78 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | 27.1% | BTIG | Ryan Zimmerman71% | $72 → $75 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 20.32% | Morgan Stanley | Drew Ranieri47% | $67 → $71 | Maintains | Equal-Weight | Get Alert |
| 05/29/2024 | Buy Now | 22.01% | BTIG | Ryan Zimmerman71% | $63 → $72 | Maintains | Buy | Get Alert |
| 05/20/2024 | Buy Now | 35.57% | Piper Sandler | Matt O'Brien52% | $60 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 05/09/2024 | Buy Now | 44.04% | Barclays | Matt Miksic77% | $83 → $85 | Maintains | Overweight | Get Alert |
| 05/08/2024 | Buy Now | 6.76% | BTIG | Ryan Zimmerman71% | $60 → $63 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 1.68% | Piper Sandler | Matt O'Brien52% | $55 → $60 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | 18.62% | Stifel | Mathew Blackman63% | $64 → $70 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 03/18/2024 | Buy Now | 1.68% | BTIG | Ryan Zimmerman71% | → $60 | Upgrade | Neutral → Buy | Get Alert |
| 02/21/2024 | Buy Now | 33.88% | Canaccord Genuity | Caitlin Cronin32% | → $79 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | Buy Now | 1.68% | Truist Securities | Richard Newitter74% | $58 → $60 | Maintains | Hold | Get Alert |
| 01/11/2024 | Buy Now | 18.62% | RBC Capital | Shagun Singh43% | $70 → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 12/22/2023 | Buy Now | -1.71% | Truist Securities | Richard Newitter74% | $53 → $58 | Maintains | Hold | Get Alert |
| 12/20/2023 | Buy Now | 20.32% | Canaccord Genuity | Kyle Rose55% | $67 → $71 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | -10.18% | Morgan Stanley | Drew Ranieri47% | $60 → $53 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | -10.18% | Truist Securities | Richard Newitter74% | $58 → $53 | Maintains | Hold | Get Alert |
| 10/20/2023 | Buy Now | 27.1% | Roth MKM | Jason Wittes55% | → $75 | Initiates | → Buy | Get Alert |
| 10/12/2023 | Buy Now | 45.74% | Barclays | Matt Miksic77% | $77 → $86 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | 3.37% | Stifel | Mathew Blackman63% | → $61 | Upgrade | Hold → Buy | Get Alert |
| 09/15/2023 | Buy Now | -1.71% | Wells Fargo | Vik Chopra49% | $63 → $58 | Maintains | Equal-Weight | Get Alert |
| 09/05/2023 | Buy Now | 10.15% | Truist Securities | Richard Newitter74% | → $65 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | Buy Now | 10.15% | Truist Securities | Richard Newitter74% | $68 → $65 | Maintains | Hold | Get Alert |
| 08/07/2023 | Buy Now | 30.49% | Barclays | Matt Miksic77% | $75 → $77 | Maintains | Overweight | Get Alert |
| 08/04/2023 | Buy Now | 6.76% | Wells Fargo | Vik Chopra49% | $61 → $63 | Maintains | Equal-Weight | Get Alert |
| 07/19/2023 | Buy Now | 15.23% | Truist Securities | Richard Newitter74% | $64 → $68 | Maintains | Hold | Get Alert |
| 05/31/2023 | Buy Now | 1.68% | Morgan Stanley | Drew Ranieri47% | $64 → $60 | Maintains | Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | — | JMP Securities | David Turkaly60% | — | Reiterates | → Market Perform | Get Alert |
| 05/05/2023 | Buy Now | 8.46% | Truist Securities | Richard Newitter74% | $66 → $64 | Maintains | Hold | Get Alert |
| 03/30/2023 | Buy Now | 13.54% | Canaccord Genuity | Kyle Rose55% | → $67 | Upgrade | Hold → Buy | Get Alert |
| 03/28/2023 | Buy Now | 13.54% | Canaccord Genuity | Kyle Rose55% | → $67 | Reiterates | → Hold | Get Alert |
| 02/22/2023 | Buy Now | 8.46% | Morgan Stanley | Drew Ranieri47% | $78 → $64 | Maintains | Equal-Weight | Get Alert |
| 02/22/2023 | Buy Now | 13.54% | Canaccord Genuity | Kyle Rose55% | $75 → $67 | Maintains | Hold | Get Alert |
| 02/22/2023 | Buy Now | 3.37% | Wells Fargo | Vik Chopra49% | $67 → $61 | Maintains | Equal-Weight | Get Alert |
| 02/13/2023 | Buy Now | 6.76% | B of A Securities | Craig Bijou79% | $83 → $63 | Downgrade | Buy → Underperform | Get Alert |
| 02/10/2023 | Buy Now | 13.54% | Wells Fargo | Vik Chopra49% | $82 → $67 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 18.62% | Truist Securities | Richard Newitter74% | → $70 | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | 18.62% | Loop Capital | Jason Wittes55% | $90 → $70 | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | — | Needham | David Saxon56% | — | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | — | BTIG | Ryan Zimmerman71% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/09/2023 | Buy Now | — | Piper Sandler | Matt O'Brien52% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 32.18% | Morgan Stanley | Drew Ranieri47% | $68 → $78 | Maintains | Equal-Weight | Get Alert |
| 12/20/2022 | Buy Now | 44.04% | Truist Securities | Richard Newitter74% | $74 → $85 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | 38.96% | Wells Fargo | Vik Chopra49% | $74 → $82 | Maintains | Overweight | Get Alert |
| 11/09/2022 | Buy Now | 15.23% | Morgan Stanley | Drew Ranieri47% | $66 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | 16.93% | Barclays | Matt Miksic77% | → $69 | Initiates | → Overweight | Get Alert |
| 10/12/2022 | Buy Now | 27.1% | Jefferies | Matthew Taylor74% | → $75 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 11.85% | Morgan Stanley | Drew Ranieri47% | $62 → $66 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | Buy Now | 27.1% | Piper Sandler | Matt O'Brien52% | $80 → $75 | Maintains | Overweight | Get Alert |
| 07/20/2022 | Buy Now | 20.32% | Truist Securities | Richard Newitter74% | $76 → $71 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 5.07% | Morgan Stanley | Drew Ranieri47% | $68 → $62 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Globus Medical (GMED) stock?
The latest price target for Globus Medical (NYSE:GMED) was reported by Truist Securities on May 12, 2025. The analyst firm set a price target for $68.00 expecting GMED to rise to within 12 months (a possible 15.23% upside). 42 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Globus Medical (GMED)?
The latest analyst rating for Globus Medical (NYSE:GMED) was provided by Truist Securities, and Globus Medical maintained their hold rating.
When was the last upgrade for Globus Medical (GMED)?
The last upgrade for Globus Medical Inc happened on January 9, 2025 when B of A Securities raised their price target to $97. B of A Securities previously had an underperform for Globus Medical Inc.
When was the last downgrade for Globus Medical (GMED)?
The last downgrade for Globus Medical Inc happened on February 13, 2023 when B of A Securities changed their price target from $83 to $63 for Globus Medical Inc.
When is the next analyst rating going to be posted or updated for Globus Medical (GMED)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Globus Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Globus Medical was filed on May 12, 2025 so you should expect the next rating to be made available sometime around May 12, 2026.
Is the Analyst Rating Globus Medical (GMED) correct?
While ratings are subjective and will change, the latest Globus Medical (GMED) rating was a maintained with a price target of $80.00 to $68.00. The current price Globus Medical (GMED) is trading at is $59.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
